Table 1 Baseline clinical characteristics and laboratory findings
RB (n = 151) | GHRR (n = 98) | p value | |
|---|---|---|---|
Clinical characteristics | |||
Gender (male) | 77 (51.0%) | 47 (48.0%) | 0.698 |
Age | 60.24 ± 18.41 | 53.52 ± 23.47 | 0.018 |
Diabetes | 40 (26.5%) | 15 (15.3%) | 0.038 |
Hypertension | 64 (42.4%) | 33 (33/7%) | 0.169 |
CKD | 9 (6.0%) | 9 (9.2%) | 0.609 |
COPD | 10 (6.7%) | 4 (4.1%) | 0.389 |
Malignancy (recent) | 7 (4.7%) | 1 (1.0%) | 0.115 |
Laboratory findings at admission | |||
WBC (× 103/µL) | 5.51 ± 2.83 | 6.16 ± 3.94 | 0.172 |
Hb (g/dL) | 13.21 ± 1.67 | 13.18 ± 1.82 | 0.911 |
Hct (%) | 38.91 ± 4.70 | 39.31 ± 6.66 | 0.583 |
Platelet (× 103/µL) | 153.50 ± 68.78 | 211.84 ± 74.15 | 0.082 |
PT (s) | 12.33 ± 2.23 | 12.34 ± 1.67 | 0.985 |
AST (IU/L) | 44.40 ± 27.57 | 42.87 ± 28.39 | 0.701 |
ALT (IU/L) | 34.44 ± 27.66 | 36.43 ± 31.34 | 0.605 |
Total bilirubin (mg/dL) | 0.63 ± 0.37 | 0.63 ± 0.31 | 0.966 |
Albumin (g/dL) | 4.25 ± 0.47 | 4.18 ± 0.55 | 0.279 |
Creatinine (mg/dL) | 0.97 ± 1.29 | 0.86 ± 0.46 | 0.444 |
CRP (mg/L) | 49.35 ± 59.34 | 55.41 ± 66.46 | 0.466 |